A Study to Determine the Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Dark Circles

Inclusion Criteria: * Subjects (male and female), aged 18 to 55 years (both inclusive) with Periorbital Hyperpigmentation. * Subject willing to refrain from any other treatment of Periorbital Hyperpigmentation during entire study duration. * Subjects who are willing to give informed consent and adhere to the study protocol. Exclusion Criteria: * Subjects aged less than 18 and more than 55 years * Subjects with history of connective tissue disease. * Subjects with metabolic or hematopoietic disorders * Subjects unwilling to or unable to comply with the study protocol. * Subjects taking concomitant therapy that might interfere with the study results in the investigator's opinion or participating in another trial in the past 30 days.